← FDA Drug Approvals (Drugs@FDA)
DIVALPROEX SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2025-08-12
Drug application
- FDA Application #
ANDA217358- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIVALPROEX SODIUM
- Generic name
- DIVALPROEX SODIUM
- Active ingredients
- DIVALPROEX SODIUM
- Dosage form
- CAPSULE, DELAYED REL PELLETS
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MANKIND PHARMA
- Manufacturer
- First Nation Group, LLC
- First approval
- 2025-08-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown